Mon panier

Activin RIIB

Activin RIIB Informations sur la molécule

Nom anglaisActivin receptor type-2BNombre de médicaments commercialisés0
Nombre de médicaments cliniques6Alias de la cibleEC:2.7.11.30,EC 2.7.11,Activin receptor type IIB,ACVR2B,Activin A Receptor Type 2B,Activin A Receptor, Type IIB,Activin Receptor Type-2B,EC 2.7.11.30,ActR-IIB,ACTRIIB,HTX4
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisActivin receptor type-2B
Alias de la cibleEC:2.7.11.30,EC 2.7.11,Activin receptor type IIB,ACVR2B,Activin A Receptor Type 2B,Activin A Receptor, Type IIB,Activin Receptor Type-2B,EC 2.7.11.30,ActR-IIB,ACTRIIB,HTX4
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques6
Phase de R&D la plus avancéePhase 2 Clinical

Activin RIIB Liste de produits

  • Attribut

    Protein (7)

  • Bibliothèque de produits

    En ligne (7)

  • Espèces

    Human (4)Mouse (2)Rabbit (1)

  • Étiquette

    His Tag (3)His Tag & Avi Tag (2)Fc Tag (1)Fc Tag & Avi Tag (1)

  • Marqueur

    Unconjugated (4)Biotin-labeled (3)

Activin RIIBContexte de la molécule

Activin receptor type-2B (ACVR2B) is also known as ActR-IIB and MGC116908, ACVR2B is an activin type 2 receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. This gene encodes activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. Defects in ACVR2B are the cause of visceral heterotaxy autosomal type 4 (HTX4).

Activin RIIBAlias de la molécule

ACVR2B,ACTRIIB,MGC116908

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
BimagrumabLY-3985863; BYM-338Phase 2 ClinicalMorphosys Ag, Novartis Pharma AgDiabetes Mellitus, Type 2; Myositis, Inclusion Body; Obesity; Overweight; Pulmonary Disease, Chronic Obstructive; Sarcopenia
Details
BIIB-110BIIB-110; BIIB110; ALG-801Phase 1 ClinicalAlivegen USA IncMuscular Atrophy, Spinal; Muscular Diseases
Details
LAE-103LAE-103; LAE103Phase 1 ClinicalLaekna Therapeutics Shanghai Co LtdMuscular Diseases; Muscular Disorders, Atrophic; Obesity; Sarcopenia
Details
SSS-67SSS67; SSS-67Phase 1 ClinicalShenyang Sunshine Pharmaceutical Co LtdObesity; Overweight
Details
JMT-206JMT206; JMT-206Phase 1 ClinicalShanghai Jmt-Bio IncBody Weight; Obesity; Overweight; Sarcopenia
Details
Tirzepatide/BimagrumabLY-900042Phase 1 ClinicalEli Lilly And Company
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques